Stepan Alex Emilian

Prof. Dr. Stepan Alex Emilian

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2022
Verified
Journal Article
Open access
ACAlexandra-Roxana Ciuciulete
Alexandra-Roxana Ciuciulete
SEStepan Alex Emilian
Stepan Alex Emilian
BABianca Cătălina Andreiana
Bianca Cătălina Andreiana
CSCristiana Eugenia Simionescu
Cristiana Eugenia Simionescu
Non-melanoma skin cancer (NMSC) represent an important health problem in medical practice. This is the most frequent type of cancer and its incidence is constantly increasing. Basal cell carcinoma and squamous cell carcinoma constitute the majority of NMSC, respectively 70% and 25% of total cases. The present retrospective study was conducted over a one-year period and included 439 cases of NMSC, of which 336 BCC and 103 SCC. We analyzed a series of clinical parameters: gender, age, tumor size and tumor topography. The statistical analysis of the investigated parameters indicated gender-age associations for BCC, and topography-gender, as well as topography-age for SCC.

1 January 2012
Verified
Journal Article
Closed access
ARANCA ROȘU
ANCA ROȘU
CMCl Mărgăritescu
Cl Mărgăritescu
SEStepan Alex Emilian
Stepan Alex Emilian
AMAnca Muşetescu
Anca Muşetescu
MEM Ene
M Ene

22 December 2020 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
ADAlice Nicoleta Drăgoescu
Alice Nicoleta Drăgoescu
Vlad PadureanuVlad Padureanu
Vlad Padureanu
ASAndreea Doriana Stănculescu
Andreea Doriana Stănculescu
CLChiutu Luminita
Chiutu Luminita
DFDan Nicolae Florescu
Dan Nicolae Florescu
ODOctavian Petru Drăgoescu
Octavian Petru Drăgoescu
The 2016 Surviving Sepsis Campaign guidelines define sepsis as life-threatening organ dysfunction caused by a dysregulated host response to infection. This study had the objective of assessing the efficacy of presepsin in the prognosis of sepsis. This was a single-center prospective study, performed in Craiova Emergency Hospital, that included 114 patients admitted in the Intensive Care Unit (ICU) department between 2018 and 2019 fulfilling the sepsis criteria. Including criteria were: age ≥ 18, sepsis diagnosed by the Sequential Organ Failure Assessment (SOFA) score of pulmonary, abdominal, urinary, surgical or unknown origin, as well as lactate levels ≥ 2 mmol/l and need of vasopressors for mean arterial pressure (MAP) ≥ 65 mmHg, despite adequate volume resuscitations for patients with septic shock. Patients younger than 18, pregnant, immunocompromised, or with terminal illnesses were excluded. Based on disease severity, patients were distributed into two study groups: sepsis—76 patients and septic shock—38 patients. As expected, SOFA score and most of its components (PaO2/FiO2, platelets, and Glasgow Coma Score (GCS)) were significantly modified for patients with septic shock compared to those in the sepsis group and for survivors versus non-survivors. Overall death rate was 34.2%, with a significantly higher value for patients with septic shock (55.3% vs. 23.7%, p = 0.035). Sepsis marker presepsin was significantly elevated in all patients (2047 ng/mL) and significantly increased for the septic shock patients (2538 ng/mL, p < 0.001) and non-survivors (3138 ng/mL, p < 0.001). A significant correlation was identified between the SOFA score and presepsin (r = 0.883, p < 0.001). The receiver operating characteristics (ROC)-Area Under Curve (AUC) analysis showed significant prognostic values for presepsin regarding both sepsis severity (AUC = 0.726, 95% confidence interval CI = 0.635–0.806) and mortality risk (AUC = 0.861, 95%CI = 0.784–0.919). In conclusion, under the revised definition of sepsis, presepsin could be a useful marker for prognosis of sepsis severity and mortality risk. Additional data are required to confirm the value of presepsin in sepsis prognosis.

1 January 2012
Verified
Journal Article
Closed access
LDL P Dragomir
L P Dragomir
CSCristiana Eugenia Simionescu
Cristiana Eugenia Simionescu
CMCl Mărgăritescu
Cl Mărgăritescu
SEStepan Alex Emilian
Stepan Alex Emilian
IDIuliana Manuela Dragomir
Iuliana Manuela Dragomir
MPM R Popescu
M R Popescu

15 July 2018
Verified
Journal Article
Open access
RMRadu Mitrut
Radu Mitrut
SEStepan Alex Emilian
Stepan Alex Emilian
DPD. Pirici
D. Pirici
Dilated cardiomyopathy is the most common form of cardiac muscle disease, accounting for approximately 60% of all cardiomyopathies. We proposed to identify histopathological changes of the myocardium in dilative cardiomyopathy. This study comprised a total of 19 cases, represented by myocardial fragments from deceased patients with diagnosis of dilated cardiomyopathy. Histopathological analysis allowed changes to be observed for both myocytes and myocardial interstitial components. We have found a combination of hypertrophic, atrophic and normal myocardocytes, or associated with the presence of hydropic changes. We rarely identified the aspect of myocytosis, cytoplasmic accumulation of lipofuscin pigment or mucinous material, and variable nuclear pleomorphism. At the interstitial level we noticed changes in fibrosis, lipomatosis and rarely the presence of inflammatory infiltrate. Histopathological characteristics of the myocardium in dilated cardiomyopathy are numerous but nonspecific, similar to those in the terminal stages of other cardiac diseases.

1 January 2009
Verified
Journal Article
Closed access
CMCLAUDIU MARGARITESCU
CLAUDIU MARGARITESCU
DPDaniel Pirici
Daniel Pirici
CSCristiana Eugenia Simionescu
Cristiana Eugenia Simionescu
LMLaurentiu Mogoantă
Laurentiu Mogoantă
MRM Raica
M Raica
DRD Ribatti
D Ribatti